Immune-related RELT drives clear cell renal cell carcinoma progression through JAK/STAT signaling pathway activation
RELT promotes the development of ccRCC and may play a role in regulating the tumor immune microenvironment, which affects the prognosis of ccRCC patients, and RELT may become a new biomarker associated with immune infiltration in ccRCC.
Authors
- Jitao Wu
- Yingying Yang (ORCID: https://orcid.org/0000-0001-5115-8375)
- Tianqi Wang (ORCID: https://orcid.org/0000-0002-7503-602X)
- Yini Wang (ORCID: https://orcid.org/0000-0002-1154-6733)
- Xiaohong Ma (ORCID: https://orcid.org/0000-0001-8625-237X)
Institutions
- Shandong University of Aeronautics (CN)
- Yuhuangding Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.3389/fimmu.2025.1659119
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00